Member Info for Moneymaker2015

Yeh I agree it doesn’t look like there’s a bounce going on at the moment. It’s a shame actually, I thought the recent rally may have propped us up above 12p and kept us there.

I genuinely think the low share price is purely down to sentiment. People know they can make quicker (although riskier) money elsewhere. You just have to look on EUA’s board lately, so many people are saying they’ve sold all their other holdings to load-up there, because they see it as an sure way of doubling or tripling their money in the short term. I actually think we’ll see an influx of money here too once that sale is concluded and people look to put their profits in a safer long term holding.

Gmf, its good to see someone else with a realistic outlook.

I’ve seen some of the stuff you’ve put on twitter actually about EUA, makes for a good read.

It’s not common practice, they are only obliged to publish the offer they believe to be the best value for shareholders. This doesn’t necessarily mean best upfront price either as one party provide a low upfront cost or none at all, but provide shares within their company instead, equating to a given value.

Wolster, I wasn’t going to filter you because I don’t want yet another green box coming up on this feed. However, seeing as the only thing you seem to do is claim I’m a trader because I don’t mislead people into thinking they’re going to 10 bag from the current price levels, you bring absolutely nothing of any relevance to the table, so goodbye for now.

It’s amusing reading some people’s comments on here. They know so little about the company they’re preaching about.

To those talking about 40m oz, EUA only currently holds a licence for a little over 2m oz and have applied for this to go up to 15m. They DO NOT own 40m oz. Yes some ‘may’ take the suspected additional into consideration but won’t be placing bids at full value on it. Some companies shareholders will not even all them to make any allowance for it in their bids because of the high level of risk. Similarly, the flanks will not be valued pro-rata to the current licence area that has already had a full drill programme carried out.

Another one, to the people saying 15m oz of Pd and valuing it this way. Look at the drill results for MT from a few years back. You’ll clearly see the area is roughly on a 2:1 Pd:Pt basis and not just Palladium.

It will take you less than 5 mins to confirm what I’ve said above because it’s in 2 of the companies RNS’s. Don’t just listen to what people are saying on this board.

I wouldn’t be overly concerned with CINE defaulting. The link you copied even highlights that provided there is some visibility that attendances slowly head back to normal between August and Q42021, so the next year and a half effectively, the rating will be increased. Plus, if you have a look at the financial statement for last year on revenues of $4.3b, CINE had an EBITA of $1.58b, paid off finance costs of $568m and still had a before tax profit of $212m. When their doors are open they are in a very healthy position and have no problem paying off financing facilities.

The UK have pretty much confirmed they won’t do another nationwide lockdown and in the future it will be down to individual regions to police the situation. Similarly, the US will be doing it on a state by state basis.

I think the thing we can all agree on though is that CINE has a tendency to fluctuate rapidly, so the opening of cinemas next week is likely to provide a sharp increase in the share price from the current levels.

The decrease to 55% comes down to the anticipated EBITA. CINE is still within RR3 as it was last year and would likely have risen to RR2 had the pandemic not come about. The opening of cinemas next week will likely prevent us dropping into RR4 too.

It’s a very good report and highlights that CINE aren’t in a position where they are desperate for a return to normality. 2021 is likely to be a huge turning point, especially with the number of films set for release. The only major cause for concern is the legal battle with Cineplex as the results are unforeseen. However, I’d like to think that some form of due diligence was undertaken and evidence of breaches were retrieved prior to CINE terminating the agreement.

Indepth,

Very good article that. Shows that CINE is in a very good position all things considered. It’s good to read that they’ll be absolutely fine even with delayed releases causing minimal attendance for the coming months and attendance not returning to ‘normal’ levels until Q42021.

Overall, a bright future ahead for those willing to hold tight.

I don’t tend to trade myself because I have rotten luck and miss out on big news whenever I have in the past. Anyone that is trading CINE at the moment could be making a fortune. It seems almost every day or every other day that the share price drops to 52-53p, then the following day is back to 56-57p. That’s some hefty margins if you’re doing it on a regular basis. Part of me is slightly tempted, but I know as soon as I hit that sell button we’ll get some great news to fires us back to 70p or higher...

It’s just like Kat all over again, which means KIBO’s percentage will gradually decrease over the years.

LC has done well for himself over the years. He’s now in a position that if KIBO goes bump he can keep going through KAT and MED.

The only positive that I can see if that MED being listed as a separate entity will likely bring in a decent amount of new interest, which will assist in any fund raise required to get MED off the ground. Luckily MED is a project that can quickly get off the ground, if KIBO is to ever get a return from it, it shouldn’t be in the too distant future.

I’m confused, they had an exercise price of 0.5p. The share price currently sits at 0.22p... Why would someone go for this, or am I missing something?

They’re talking about the Pandemic when they talk about current market conditions. Gold being at its peak will assist BMV, but funding in general has been tightened due to economic uncertainty.

They signed a legally binding agreement in March, which Aidan said shortly after they expect in June/July. Most companies talk about things that can’t be guaranteed, so you have to assume they’re saying this until the money is in the bank before committing anything in writing to shareholders. Considering it’s legally binding, I’d like to think there’s a high likelihood that it will be received.

On the plus side, they have stated there’s other funding options available should the current one collapse.

That’s what I’ve been saying for a while. Just sit and wait.

There’s probably an unfortunate few here that got in over 40p, but if you look what the company is doing as a whole, once profits start being realised the share price will eventually follow. As far as AIM shares go, this is a solid performer and even though delaying the Mokopane DFS wasn’t the best of news, it’s kept the company in a strong cash position.

As you say, the NAV puts us in one position, the cash flow slightly higher. You could happily purchase these currently up to 25p and have no concern. Higher share prices will follow as the years go on and the company expands. I’m holding out for EUA to pull it’s finger out with their sale because I’ve got a few shares I’d like to top-up at their current prices and BMN is one of them.

Lib, you right on the money there. I was originally in at 2p and sold out around 20p, very prematurely because I never imagined the rise to continue to near 50p considering where we were as a company. We’re in exactly the same situation again but with different price levels.

Being in a position of growth, the current share price represent a good bargain for anyone coming in now, if they’re willing to wait. The x8 of the current share price that people have spoke about may potentially happen, but it’s still a way off yet. That would give us an mcap near £1b, which is significantly higher than our current NAV and earnings. The share price will almost inevitably go up in the long term, but in the short term we may also go slightly lower. It just comes down to how urgent investors are for their returns.

True, but by ‘big news’ I was talking more along the lines of news that would have a significant shift in share price. Considering Q1 results and the financials have had little effect on the share price, I’m not anticipating anything earth shattering from Q2. Moreso because that was through the height of the pandemic too.

Once it went back above 15p I admit I didn’t think we’d see 10p but now I think you may be right. Worst bit is we’re not expecting big news anytime soon either. Just look at it on the bright side, sub-10p would provide a very good price for a top-up.

It’s just because there are more sells going through than buys at the moment. The consensus seems to be that some people don’t want to wait around for news to drop.

I’m hoping some news of an offer comes in at EUA so I can have a little top-up here.

It definitely seems like a case of waiting until the money is in the bank before they announce anything. A little unusual, but so long as they confirm financing it’ll be worth the wait.

Naturally, this will inevitably head towards 100p again long term. The only risk I see are the legal proceedings, which may put off some investors. Once that’s all done and dusted this will start flying. Purely just a waiting game.

To be fair the RNS isn’t bad news. Whilst it means waiting a while for funding to be confirmed, at least they have agreed a formal date for a decision now.

I’d be wary about topping up, even if the share price does drop a little lower but on the other hand I definitely won’t be selling as with so few shares issued its definitely got upside potential if everything works out.